Cargando…
A Three lncRNA Set: AC009975.1, POTEH-AS1 and AL390243.1 as Nodal Efficacy Biomarker of Neoadjuvant Therapy for HER-2 Positive Breast Cancer
PURPOSE: The study aimed to explore whether the expression of lncRNAs in primary tumors could predict nodal efficacy after neoadjuvant therapy (NAT) for HER2+ breast cancer. METHODS: Total RNA was extracted from HER2+ breast cancer tissues before NAT (n=103) and from 48 pairs of cancers and para-can...
Autores principales: | Bi, Zhao, Qiu, Peng-Fei, Zhang, Yue, Song, Xing-Guo, Chen, Peng, Xie, Li, Wang, Yong-Sheng, Song, Xian-Rang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685269/ https://www.ncbi.nlm.nih.gov/pubmed/34938660 http://dx.doi.org/10.3389/fonc.2021.779140 |
Ejemplares similares
-
LncRNA AC093818.1 accelerates gastric cancer metastasis by epigenetically promoting PDK1 expression
por: Ba, Ming-chen, et al.
Publicado: (2020) -
A lncRNA landscape in breast cancer reveals a potential role for AC009283.1 in proliferation and apoptosis in HER2-enriched subtype
por: Cedro-Tanda, Alberto, et al.
Publicado: (2020) -
H3K18ac Primes Mesendodermal Differentiation upon Nodal Signaling
por: Luo, Maoguo, et al.
Publicado: (2019) -
Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma
por: Gan, Binliang, et al.
Publicado: (2023) -
LncRNA AC007255.1, an immune-related prognostic enhancer RNA in esophageal cancer
por: Wang, Qingqing, et al.
Publicado: (2021)